Peer Recovery Support for Opioid Use Disorder
(PRSS Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if peer recovery support can assist individuals with opioid use disorder in starting medication treatment during a residential program. It emphasizes support from those with similar experiences to encourage the initiation of medications like methadone, buprenorphine, or naltrexone. The PRSS intervention for MOUD initiation is tested for practicality and participant satisfaction. It suits individuals seeking inpatient treatment who have not recently begun medication treatment and can access medication through insurance. As an unphased trial, this study provides a unique opportunity for patients to contribute to innovative approaches in addiction recovery.
Will I have to stop taking my current medications?
The trial requires that you have not taken sublingual buprenorphine or methadone within 14 days before starting the inpatient treatment, and you must not have received XR-buprenorphine or XR-naltrexone within 45 days before starting. If you are currently on these medications, you may need to stop them before participating.
What prior data suggests that this PRSS intervention is safe for MOUD initiation?
Research shows that Peer Recovery Support Services (PRSS) are generally safe for people with opioid use disorder (OUD). A review of studies found that PRSS helps reduce drug use and the chances of relapse, while also helping people stay in treatment longer. Additionally, research has shown that peer support can improve relationships with healthcare providers and strengthen social support networks, leading to fewer cases of substance use disorder (SUD) and relapse.
While specific safety data for PRSS in this trial is not available, PRSS has been used in emergency departments before. In those cases, PRSS was linked to more people starting medications for opioid use disorder (MOUD) and fewer repeated overdoses. Although exact safety data for PRSS in residential settings is lacking, its use in other settings suggests it is well-tolerated and safe for participants.12345Why are researchers excited about this trial?
Researchers are excited about the Peer Recovery Support Services (PRSS) intervention for opioid use disorder because it offers a fresh approach to starting medication-assisted treatments like buprenorphine, methadone, or naltrexone. Unlike traditional treatments that focus solely on medication, PRSS emphasizes peer support, which can enhance motivation and adherence by connecting individuals with others who have successfully managed their recovery. This peer-driven model can provide emotional support and practical advice, potentially improving initiation and retention rates in medication for opioid use disorder (MOUD) programs. By leveraging the power of shared experiences, PRSS aims to complement existing medical treatments and address the social and emotional aspects of recovery, which are often overlooked in conventional approaches.
What evidence suggests that this PRSS intervention is effective for MOUD initiation?
Research has shown that peer recovery support services (PRSS) can help individuals start medications for opioid use disorder (MOUD). This trial will focus on the PRSS intervention for MOUD initiation. While studies have found PRSS to be helpful in emergency settings, its effects in residential treatment settings remain under investigation. PRSS aims to support individuals starting MOUD by providing motivation and sharing experiences from peers who have faced similar challenges. Although more research is needed, early findings suggest that PRSS can encourage individuals to begin and continue MOUD treatment, potentially lowering the risk of relapse and overdose.26789
Are You a Good Fit for This Trial?
This trial is for adults over 18 with Opioid Use Disorder (OUD) who are seeking inpatient treatment at Maryland Treatment Centers, speak English, can consent to the study, and have insurance coverage for Medications for Opioid Use Disorder (MOUD).Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive an 8-week course of Peer Recovery Support Services (PRSS) to promote MOUD initiation during inpatient SUD treatment
Follow-up
Participants are monitored for MOUD initiation and retention after discharge from inpatient treatment
What Are the Treatments Tested in This Trial?
Interventions
- PRSS intervention for MOUD initiation
Find a Clinic Near You
Who Is Running the Clinical Trial?
Potomac Health Foundations
Lead Sponsor
National Institute of Drug Abuse
Collaborator
National Institutes of Health (NIH)
Collaborator
National Institute on Drug Abuse (NIDA)
Collaborator